DHAI (DIH Holding US) Debt-to-Equity: -0.40 (As of Mar. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is DIH Holding US Debt-to-Equity?

DIH Holding US DHAI Debt-to-Equity is -0.40 as of Mar. 2025.

DIH Holding US's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2025 was $3.12 Mil. DIH Holding US's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2025 was $11.77 Mil. DIH Holding US's Total Stockholders Equity for the quarter that ended in Mar. 2025 was $-37.14 Mil. DIH Holding US's debt to equity for the quarter that ended in Mar. 2025 was -0.40.

A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.

The historical rank and industry rank for DIH Holding US's Debt-to-Equity or its related term are showing as below:

DHAI's Debt-to-Equity is not ranked *
in the Medical Devices & Instruments industry.
Industry Median: 0.22
* Ranked among companies with meaningful Debt-to-Equity only.

DIH Holding US  (OTCPK:DHAI) Debt-to-Equity Explanation

In the calculation of Debt to Equity, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Stockholders Equity. In some calculations, Total Liabilities is used to for calculation.

Be Aware

Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.

DIH Holding US Debt-to-Equity Related Terms

DIH Holding US Debt-to-Equity Historical Data

* Premium members only.

The historical data trend for DIH Holding US's Debt-to-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

DIH Holding US Debt-to-Equity Chart

DIH Holding US Annual Data
Trend Mar22 Mar23 Mar24 Mar25
Debt-to-Equity
-0.89 -0.63 -0.49 -0.40

DIH Holding US Quarterly Data
Mar22 Dec22 Mar23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Debt-to-Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.49 -0.52 -0.48 -0.40 -0.40

DHAI vs ABT, SYK, MDT: Debt-to-Equity Comparison

For the Medical Devices subindustry, DIH Holding US's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

DIH Holding US Debt-to-Equity vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, DIH Holding US's Debt-to-Equity distribution charts can be found below:

* The bar in red indicates where DIH Holding US's Debt-to-Equity falls into.


DIH Holding US Debt-to-Equity Calculation

Debt to Equity measures the financial leverage a company has.

DIH Holding US's Debt to Equity Ratio for the fiscal year that ended in Mar. 2025 is calculated as

Debt to Equity=Total Debt / Total Stockholders Equity
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Total Stockholders Equity
=(3.118 + 11.773) / -37.135
=-0.40

DIH Holding US's Debt to Equity Ratio for the quarter that ended in Mar. 2025 is calculated as

Debt to Equity=Total Debt / Total Stockholders Equity
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Total Stockholders Equity
=(3.118 + 11.773) / -37.135
=-0.40

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Debt-to-Equity →
What does a Debt-to-Equity of -0.40 mean?
DIH Holding US (DHAI) has a Debt-to-Equity of -0.40 as of Mar. 2025. Debt-to-Equity ratio represents the ratio of total debt to total company equity. View historical data on DIH Holding US and its competitors.
Is DIH Holding US's Debt-to-Equity too high?
DIH Holding US's current Debt-to-Equity is -0.40.
How does DIH Holding US's Debt-to-Equity compare to ABT and SYK?
DIH Holding US's Debt-to-Equity of -0.40 can be compared against companies in the Medical Devices & Instruments industry. The industry median Debt-to-Equity is 0.22. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Debt-to-Equity for a Medical Devices & Instruments company?
The median Debt-to-Equity among Medical Devices & Instruments companies is 0.22, based on 702 companies in the industry. Companies in the top quartile (top 25%) have a Debt-to-Equity significantly above this median, while those in the bottom quartile fall well below. However, Debt-to-Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Debt-to-Equity mean?
A high Debt-to-Equity can signal that a stock is expensive relative to its fundamentals. Debt-to-Equity ratio represents the ratio of total debt to total company equity. View historical data on DIH Holding US and its competitors. For the Medical Devices & Instruments industry, the median Debt-to-Equity is 0.22 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. DIH Holding US's current Debt-to-Equity is -0.40. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is DIH Holding US stock overvalued right now?
DIH Holding US (DHAI) has a current Debt-to-Equity of -0.40. The current Debt-to-Equity is -0.40. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Debt-to-Equity calculated?
Debt-to-Equity is calculated from a company's financial statements. For DIH Holding US (DHAI), the current Debt-to-Equity is -0.40 as of Mar. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

DIH Holding US Business Description

Address 77 Accord Park Drive, Suite D-1, Norwell, MA, USA, 02061
DIH Holding US Inc is a provider of robotic devices used in physical rehabilitation, which incorporate visual stimulation in an interactive manner to enable clinical research and intensive functional rehabilitation and training in patients with walking impairments, reduced balance and/or impaired arm and hand functions. It serves the healthcare systems, clinics, third-party healthcare providers, distributors and other institutions by providing a broad array of devices and services focused on the customer and patient recovery. Its key products are LokoMat, Erigo, Armeo, C-Mill and CAREN/Grail. Geographically, the company derives revenue from the EMEA, Americas, and Asia Pacific regions. The company generates revenue from the sale of medical rehabilitation devices and technology.